The HPV transcriptome in HPV16 positive cell lines

Molecular and Cellular Probes

Volumn 25, Issue 2-3, 2011, Pages 108-113

  Schmitt, Markus ^a   Pawlita, Michael ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Cell line; HeLa; HPK IA; HPV16; Human papillomavirus 16; MRI H186; MRI H196; SiHa; Transcription

Indexed keywords

NUCLEOTIDE; TRANSCRIPTOME;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL LINE; DOWNSTREAM PROCESSING; EMBRYO; HUMAN PAPILLOMAVIRUS TYPE 16; MOUSE; NONHUMAN; NUCLEIC ACID SEQUENCE BASED AMPLIFICATION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS;

ANIMALS; CELL LINE; CELL LINE, TRANSFORMED; CELL LINE, TUMOR; CELL TRANSFORMATION, VIRAL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, VIRAL; GENOME, VIRAL; HUMAN PAPILLOMAVIRUS 16; HUMANS; MICE; MICE, INBRED C57BL; NUCLEIC ACID HYBRIDIZATION; RNA, VIRAL;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS - 16; HUMAN PAPILLOMAVIRUS TYPE 16; PAPILLOMAVIRIDAE;

EID: 79955464226     PISSN: 08908508     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mcp.2011.03.003     Document Type: Article

References (48)

1. Durst M., Gissmann L., Ikenberg H., zur Hausen H. A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions. Proceedings of the National Academy of Sciences of the United States of America 1983, 80:3812-3815.
2. Schwarz E., Freese U.K., Gissmann L., Mayer W., Roggenbuck B., Stremlau A., et al. Structure and transcription of human papillomavirus sequences in cervical carcinoma cells. Nature 1985, 314:111-114.
3. Munger K., Phelps W.C., Bubb V., Howley P.M., Schlegel R. The E6 and E7 genes of the human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes. Journal of Virology 1989, 63:4417-4421.
4. Vinokurova S., Wentzensen N., Kraus I., Klaes R., Driesch C., Melsheimer P., et al. Type-dependent integration frequency of human papillomavirus genomes in cervical lesions. Cancer Research 2008, 68:307-313.
5. Grassmann K., Rapp B., Maschek H., Petry K.U., Iftner T. Identification of a differentiation-inducible promoter in the E7 open reading frame of human papillomavirus type 16 (HPV-16) in raft cultures of a new cell line containing high copy numbers of episomal HPV-16 DNA. Journal of Virology 1996, 70:2339-2349.
6. Milligan S.G., Veerapraditsin T., Ahamet B., Mole S., Graham S.V. Analysis of novel human papillomavirus type 16 late mRNAs in differentiated W12 cervical epithelial cells. Virology 2007, 360:172-181.
7. Sherman L., Alloul N. Human papillomavirus type 16 expresses a variety of alternatively spliced mRNAs putatively encoding the E2 p.otein. Virology 1992, 191:953-959.
8. Rohlfs M., Winkenbach S., Meyer S., Rupp T., Durst M. Viral transcription in human keratinocyte cell lines immortalized by human papillomavirus type-16. Virology 1991, 183:331-342.
9. Zheng Z.M., Tao M., Yamanegi K., Bodaghi S., Xiao W. Splicing of a cap-proximal human Papillomavirus 16 E6E7 intron promotes E7 expression, but can be restrained by distance of the intron from its RNA 5' cap. Journal of Molecular Biology 2004, 337:1091-1108.
10. Doorbar J., Parton A., Hartley K., Banks L., Crook T., Stanley M., et al. Detection of novel splicing patterns in a HPV16-containing keratinocyte cell line. Virology 1990, 178:254-262.
11. Smotkin D., Wettstein F.O. Transcription of human papillomavirus type 16 early genes in a cervical cancer and a cancer-derived cell line and identification of the E7 p.otein. Proceedings of the National Academy of Sciences of the United States of America 1986, 83:4680-4684.
12. Sherman L., Alloul N., Golan I., Durst M., Baram A. Expression and splicing patterns of human papillomavirus type-16 mRNAs in pre-cancerous lesions and carcinomas of the cervix, in human keratinocytes immortalized by HPV 16, and in cell lines established from cervical cancers. International Journal of Cancer 1992, 50:356-364.
13. Schmitt M., Dalstein V., Waterboer T., Clavel C., Gissmann L., Pawlita M. Diagnosing cervical cancer and high-grade precursors by HPV16 transcription patterns. Cancer Research 2010, 70:249-256.
14. Baker C.C., Phelps W.C., Lindgren V., Braun M.J., Gonda M.A., Howley P.M. Structural and transcriptional analysis of human papillomavirus type 16 sequences in cervical carcinoma cell lines. Journal of Virology 1987, 61:962-971.
15. Shirasawa H., Tanzawa H., Matsunaga T., Simizu B. Quantitative detection of spliced E6-E7 transcripts of human papillomavirus type 16 in cervical premalignant lesions. Virology 1991, 184:795-798.
16. McNicol P., Guijon F., Wayne S., Hidajat R., Paraskevas M. Expression of human papillomavirus type 16 E6-E7 open reading frame varies quantitatively in biopsy tissue from different grades of cervical intraepithelial neoplasia. Journal of Clinical Microbiology 1995, 33:1169-1173.
17. Hsu E.M., McNicol P.J., Guijon F.B., Paraskevas M. Quantification of HPV-16 E6-E7 transcription in cervical intraepithelial neoplasia by reverse transcriptase polymerase chain reaction. International Journal of Cancer 1993, 55:397-401.
18. Hsu E.M., McNicol P.J. Characterization of HPV-16 E6/E7 transcription in CaSki cells by quantitative PCR. Molecular and Cellular Probes 1992, 6:459-466.
19. Wang-Johanning F., Lu D.W., Wang Y., Johnson M.R., Johanning G.L. Quantitation of human papillomavirus 16 E6 and E7 DNA and RNA in residual material from ThinPrep Papanicolaou tests using real-time polymerase chain reaction analysis. Cancer 2002, 94:2199-2210.
20. Pattillo R.A., Hussa R.O., Story M.T., Ruckert A.C., Shalaby M.R., Mattingly R.F. Tumor antigen and human chorionic gonadotropin in CaSki cells: a new epidermoid cervical cancer cell line. Science 1977, 196:1456-1458.
21. Baldus S.E., Schwarz E., Lohrey C., Zapatka M., Landsberg S., Hahn S.A., et al. Smad4 deficiency in cervical carcinoma cells. Oncogene 2005, 24:810-819.
22. Durst M., Dzarlieva-Petrusevska R.T., Boukamp P., Fusenig N.E., Gissmann L. Molecular and cytogenetic analysis of immortalized human primary keratinocytes obtained after transfection with human papillomavirus type 16 DNA. Oncogene 1987, 1:251-256.
23. Boukamp P., Petrussevska R.T., Breitkreutz D., Hornung J., Markham A., Fusenig N.E. Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. The Journal of Cell Biology 1988, 106:761-771.
24. Feltkamp M.C., Smits H.L., Vierboom M.P., Minnaar R.P., de Jongh B.M., Drijfhout J.W., et al. Vaccination with cytotoxic T lymphocyte epitope-containing peptide protects against a tumor induced by human papillomavirus type 16-transformed cells. European Journal of Immunology 1993, 23:2242-2249.
25. Schmitt M., Pawlita M. High-throughput detection and multiplex identification of cell contaminations. Nucleic Acids Research 2009, 37. e119.
26. Geisen C., Denk C., Gremm B., Baust C., Karger A., Bollag W., et al. High-level expression of the retinoic acid receptor beta gene in normal cells of the uterine cervix is regulated by the retinoic acid receptor alpha and is abnormally down-regulated in cervical carcinoma cells. Cancer Research 1997, 57:1460-1467.
27. Zheng Z.M., Baker C.C. Papillomavirus genome structure, expression, and post-transcriptional regulation. Frontiers in Bioscience 2006, 11:2286-2302.
28. Compton J. Nucleic acid sequence-based amplification. Nature 1991, 350:91-92.
29. Smits H.L., van Gemen B., Schukkink R., van der Velden J., Tjong A.H.S.P., Jebbink M.F., et al. Application of the NASBA nucleic acid amplification method for the detection of human papillomavirus type 16 E6-E7 transcripts. Journal of Virological Methods 1995, 54:75-81.
30. Kraus I., Molden T., Erno L.E., Skomedal H., Karlsen F., Hagmar B. Human papillomavirus oncogenic expression in the dysplastic portio; an investigation of biopsies from 190 cervical cones. British Journal of Cancer 2004, 90:1407-1413.
31. Schmitt M., Bravo I.G., Snijders P.J., Gissmann L., Pawlita M., Waterboer T. Bead-based multiplex genotyping of human papillomaviruses. Journal of Clinical Microbiology 2006, 44:504-512.
32. Yee C., Krishnan-Hewlett I., Baker C.C., Schlegel R., Howley P.M. Presence and expression of human papillomavirus sequences in human cervical carcinoma cell lines. The American Journal of Pathology 1985, 119:361-366.
33. Evans M.F., Adamson C.S., von Walstrom G.M., Cooper K. Use of multiple displacement amplification in the investigation of human papillomavirus physical status. Journal of Clinical Pathology 2007, 60:1135-1139.
34. Häfner N. Physikalischer Status des HPV16 Genoms und die virale Onkogenexpression - Bedeutung für die Zervixkarzinogenese 2007, Friedrich-Schiller Universität, Jena.
35. Forslund O., Lindqvist P., Haadem K., Czegledy J., Hansson B.G. HPV 16 DNA and mRNA in cervical brush samples quantified by PCR and microwell hybridization. Journal of Virological Methods 1997, 69:209-222.
36. De la Rosa-Rios M.A., Martinez-Salazar M., Martinez-Garcia M., Gonzalez-Bonilla C., Villegas-Sepulveda N. The intron 1 of HPV 16 has a suboptimal branch point at a guanosine. Virus Research 2006, 118:46-54.
37. Mincheva A., Gissmann L., zur Hausen H. Chromosomal integration sites of human papillomavirus DNA in three cervical cancer cell lines mapped by in situ hybridization. Medical Microbiology and Immunology 1987, 176:245-256.
38. Van Tine B.A., Kappes J.C., Banerjee N.S., Knops J., Lai L., Steenbergen R.D., et al. Clonal selection for transcriptionally active viral oncogenes during progression to cancer. Journal of Virology 2004, 78:11172-11186.
39. Durst M., Croce C.M., Gissmann L., Schwarz E., Huebner K. Papillomavirus sequences integrate near cellular oncogenes in some cervical carcinomas. Proceedings of the National Academy of Sciences of the United States of America 1987, 84:1070-1074.
40. Seagon S., Durst M. Genetic analysis of an in vitro model system for human papillomavirus type 16-associated tumorigenesis. Cancer Research 1994, 54:5593-5598.
41. De Bruijn M.L., Greenstone H.L., Vermeulen H., Melief C.J., Lowy D.R., Schiller J.T., et al. L1-specific protection from tumor challenge elicited by HPV16 virus-like particles. Virology 1998, 250:371-376.
42. Klaes R., Woerner S.M., Ridder R., Wentzensen N., Duerst M., Schneider A., et al. Detection of high-risk cervical intraepithelial neoplasia and cervical cancer by amplification of transcripts derived from integrated papillomavirus oncogenes. Cancer Research 1999, 59:6132-6136.
43. Cullen A.P., Reid R., Campion M., Lorincz A.T. Analysis of the physical state of different human papillomavirus DNAs in intraepithelial and invasive cervical neoplasm. Journal of Virology 1991, 65:606-612.
44. Matsukura T., Koi S., Sugase M. Both episomal and integrated forms of human papillomavirus type 16 are involved in invasive cervical cancers. Virology 1989, 172:63-72.
45. Schneider-Gadicke A., Schwarz E. Different human cervical carcinoma cell lines show similar transcription patterns of human papillomavirus type 18 early genes. Embo Journal 1986, 5:2285-2292.
46. Bernard B.A., Bailly C., Lenoir M.C., Darmon M., Thierry F., Yaniv M. The human papillomavirus type 18 (HPV18) E2 gene product is a repressor of the HPV18 regulatory region in human keratinocytes. Journal of Virology 1989, 63:4317-4324.
47. Jeon S., Lambert P.F. Integration of human papillomavirus type 16 DNA into the human genome leads to increased stability of E6 and E7 mRNAs: implications for cervical carcinogenesis. Proceedings of the National Academy of Sciences of the United States of America 1995, 92:1654-1658.
48. Alloul N., Sherman L. Transcription-modulatory activities of differentially spliced cDNAs encoding the E2 p.otein of human papillomavirus type 16. The Journal of General Virology 1999, 80(Pt 9):2461-2470.